Biotech

Charting
the Future of
Biotechnology

Charting
the Future of
Biotechnology

Congress charged the National Security Commission on Emerging Biotechnology with conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense.

Mission

Congress charged the National Security Commission on Emerging Biotechnology with the responsibility of examining the critical intersection of emerging biotechnology and national security. When Congress created the Commission, it defined the Commission’s formal mandate as conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future national defense activities, including activities of the Department of Defense. The Commission will submit its comprehensive report to Congress in December 2024, which will include policy recommendations that respond to our mandate. The work of the Commission will continue through June 2026 as we work to educate and expand upon our recommendations.

Commissioners

The Commission is comprised of twelve appointed members. Commissioners were selected by a bipartisan, bicameral group of Members of the House and Senate, including the Speaker of the House, House Minority Leader, Senate Majority Leader, Senate Minority Leader, and leadership of the House and Senate Armed Services Committees.

Dr. Jason Kelly
Chair
 
Senator Todd Young
Paul Arcangeli
 
Dr. Eric Schmidt
Dr. Michelle Rozo
Vice Chair
Rep. Stephanie Bice
Dr. Angela Belcher
Dr. Alexander Titus
Senator Alex Padilla
 
Rep. Ro Khanna
 
Dawn Meyerriecks
Dr. Dov Zakheim

About Us

Congress charged the National Security Commission on Emerging Biotechnology with conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense.

The Commission is a legislative branch advisory entity and is expected to provide an interim report to the President and the Armed Services Committees in December 2023 and submit a final, unclassified report in December 2024, including recommendations for action by Congress and the federal government.

If you have ideas to share or would like to contribute to the work of the Commission, please email us at ideas@biotech.senate.gov.

Careers

We welcome applicants for all positions with a strong work ethic, ability to work both independently and as part of a team, and an ability to manage multiple work streams with competing timelines.  The Commission is an equal-opportunity employer.

To apply

Send an email to jobs@biotech.senate.gov with the following information:

Email Subject

Position Name [Your Last Name]

Body of Email

Include the following:

  • Desired Start Date
  • Salary Requirements (optional)
  • Tell us in no more than 300 words why you are the right fit to join the Commission staff
  • Attach your current resume

Open Positions

Detailee 

The National Security Commission on Emerging Biotechnology seeks experienced current Federal employees for Detailee positions with the Commission’s policy and research team. Responsibilities may include research and policy development for legislative and executive action; engaging with stakeholders including other government agencies and non-government entities; drafting and editing memos, reports, and other written products; and collaborating with other Commission staff to execute on Commissioner-driven ideas and requests. Ideal candidates will have expertise relevant to biotechnology, biomanufacturing, or other emerging technologies; excellent verbal and written communication skills; experience working as part of a multi-disciplinary team; strong interpersonal, organizational, and planning skills; and the ability to adapt to a fast-paced environment. 

Contact us

Please fill out the contact form or email us directly at ideas@biotech.senate.gov